Compass Therapeutics, Inc.
CMPX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001738021
In the last 90 days, Compass Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $363.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Compass Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- 0 vs. Q1 2022
- Shares held
- 61.9M
- −482.7K (−0.8%) vs. Q1 2022
- Total value
- $163.9M
- +$78.6M (+92.1%) vs. Q1 2022
- New holders
- 6
- 6 more added
- Sold out
- 6
- 8 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 215 | $363.4M |
| Q1 2026 | 201 | $921.3M |
| Q4 2025 | 173 | $881.5M |
| Q3 2025 | 125 | $535.7M |
| Q2 2025 | 103 | $281.9M |
| Q1 2025 | 108 | $206.1M |
| Q4 2024 | 92 | $147.0M |
| Q3 2024 | 79 | $169.7M |
| Q2 2024 | 82 | $93.5M |
| Q1 2024 | 78 | $187.9M |
| Q4 2023 | 77 | $134.8M |
| Q3 2023 | 76 | $176.7M |
| Q2 2023 | 73 | $287.7M |
| Q1 2023 | 73 | $285.1M |
| Q4 2022 | 55 | $401.4M |
| Q3 2022 | 38 | $153.7M |
| Q2 2022 | 34 | $163.9M |
| Q1 2022 | 34 | $85.4M |
| Q4 2021 | 37 | $201.6M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Compass Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 21,960,850 | $58.2M | 1.06% | +317,875+1.5% | Added |
| FMR LLC | 6,872,414 | $18.2M | 0.00% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 5,328,088 | $14.1M | 0.41% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 4,406,600 | $11.7M | 0.03% | +2,129,600+93.5% | Added |
| Foresite Capital Management V, LLC | 4,400,000 | $11.7M | 8.15% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 3,347,171 | $8.80M | 0.01% | +153,877+4.8% | Added |
| CHI Advisors LLC | 2,829,712 | $7.50M | 2.87% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,000,000 | $5.30M | 0.53% | 00.0% | Unchanged |
| Avidity Partners Management LP | 2,000,000 | $5.30M | 0.12% | 00.0% | Unchanged |
| Consonance Capital Management LP | 1,603,789 | $4.22M | 17.79% | −1,896,211−54.2% | Reduced |
| Foresite Capital Opportunity Management V, LLC | 1,554,250 | $4.12M | 10.38% | +454,250+41.3% | Added |
| Blackstone Group Inc. | 1,505,738 | $3.99M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,501,973 | $3.98M | 0.00% | −70,909−4.5% | Reduced |
| Monashee Investment Management LLC | 1,230,441 | $3.26M | 1.19% | −39,770−3.1% | Reduced |
| Fred Alger Management, LLC | 608,536 | $1.61M | 0.01% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 198,094 | $525.0K | 0.14% | +2,003+1.0% | Added |
| BlackRock Inc. | 163,426 | $433.0K | 0.00% | +163,426 | New |
| LMR Partners LLP | 100,000 | $265.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 66,165 | $175.0K | 0.00% | +52,865+397.5% | Added |
| CM Management, LLC | 30,000 | $80.0K | 0.09% | −270,000−90.0% | Reduced |
| Salem Investment Counselors Inc | 30,000 | $80.0K | 0.00% | −70,000−70.0% | Reduced |
| Millennium Management LLC | 27,861 | $74.0K | 0.00% | −10,684−27.7% | Reduced |
| New Capital Management LP | 24,243 | $69.0K | 0.04% | +24,243 | New |
| Geode Capital Management, LLC | 24,857 | $65.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 23,727 | $63.0K | 0.00% | +23,727 | New |
| Mascoma Wealth Management LLC | 15,682 | $42.0K | 0.01% | 00.0% | Unchanged |
| B. Riley Wealth Management, Inc. | 14,918 | $40.0K | 0.00% | 00.0% | Unchanged |
| Flagship Harbor Advisors, LLC | 14,000 | $37.0K | 0.00% | +14,000 | New |
| UBS Group AG | 7,228 | $19.0K | 0.00% | 00.0% | Unchanged |
| Charter Oak Capital Management, LLC | 1,483 | $4.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,370 | $4.00K | 0.00% | +1,370 | New |
| Morgan Stanley | 613 | $2.00K | 0.00% | −26,364−97.7% | Reduced |
| Royal Bank of Canada | 228 | $1.00K | 0.00% | −555−70.9% | Reduced |
| Advisor Group Holdings, Inc. | 100 | $0 | 0.00% | +100 | New |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −582,750−100.0% | Sold out |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −532,958−100.0% | Sold out |
| Alphabet Inc. | 0 | $0 | 0.00% | −192,794−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −74,171−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −52,842−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −6−100.0% | Sold out |